MENU
COYA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Coya Therapeutics (COYA) Ownership - Who owns Coya Therapeutics?
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells... Show more
Profile
Industry
N/A
Address
5850 San Felipe Street
Phone
+1 800 587-8170
Employees
8
Web
https://www.coyatherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
109.72M
P/E Ratio
N/A
Total Cash
29.76M
Projected Growth
N/A
Total Debt
N/A
Revenue
423.45K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
1.78
Total Debt/Equity
N/A
Revenue/Share
0.03 USD as % of share price
Fundamentals
COYA
Capitalization
110M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
29.8M
Total Cash/Share
1.78
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.03%
Revenue
423K
ROE
N/A
Book Value
28.3M
P/B Ratio
3.88
Cash Flow
N/A
Earnings
-1.24
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.67K
Current Ratio
7.43
Current Revenue Per Employee
20452.00
Dividends Per Share - Security
N/A
EBITDA
-22.59M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-55.43
Shares Held By Institutions
23.1M
Shares Outstanding - Current
16.7M
Total Liabilities
5.14M
Total Volume MTD
N/A
Value
N/A
Gain YTD
14.485
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. COYA showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5850 San Felipe Street
Phone
+1 800 587-8170
Employees
8
Web
https://www.coyatherapeutics.com